People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Roche changing of guard: Roche Molecular Diagnostics CEO Daniel O'Day will head the Swiss firm's entire test business at year-end when current diagnostics CEO Juergen Schwiezer retires, Roche said Sept. 8. O'Day's new title will be chief operating officer, rather than CEO, of the Diagnostics Division, but like Schwiezer he will report directly to Roche CEO Severin Schwan. Under the new structure, the head of the diabetes care division, Burkhard Piper, will report to O'Day, rather than to Schwan, as Piper has been doing since 2008 when Schwan took over the company. Schwiezer took the helm of the diagnostics unit last year to replace Schwan, who previously ran the laboratory products business (1"The Gray Sheet" Oct. 8, 2007). Also as part of the changes, Pharma Division head William M. Burns will be replaced by Pascal Soriot, who has led Genentech since Roche acquired the biotech firm earlier this year
You may also be interested in...
Mindray Doubles Patient Monitor Biz, Builds U.S. Presence With Acquisition
China-based Mindray Medical will supply components for Datascope's patient monitoring business unit after acquiring the subsidiary for $202 million in a deal announced March 11
People In Brief
Diagnostics and diabetes at Roche: Jürgen Schwiezer will take the helm of Roche's diagnostics business in January, the firm announces Oct. 2. He will succeed Severin Schwan, who will become CEO of the Swiss drug and diagnostic company in March (1"The Gray Sheet" July 23, 2007, p. 10). Schwiezer is Roche Diagnostic's president for Europe, Middle East and Africa, the unit's largest market region. Also on Oct. 2, Roche announced that Burkhard G. Piper, who heads the diabetes care division, will report directly to the company CEO beginning in January, rather than reporting to Schwiezer. Roche says it is not creating a separate diabetes business unit to join its pharmaceutical and diagnostic units, but the direct CEO report signals its intention to be more aggressive in the diabetes space, where it holds the number one worldwide position in blood glucose monitors (Accu-Chek) and number two in insulin infusion. Meanwhile, Roche is set to lose its top spot in the worldwide clinical laboratory diagnostics market with Siemens' imminent acquisition of Dade Behring (2"The Gray Sheet" July 30, 2007, p. 4)
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.